Sponsors / GKOS
GKOS

Glaukos Corporation

Company identity has not yet been verified

Browse linked trials and recorded changes, or follow this company for updates.

Follow company
16Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far

Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.

Completion dates · Pro

Which trial dates moved later?

Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features

Included trials

Check company identity source
TrialSponsorPhaseStatusPrimary completion
Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic SolutionNCT02754596Glaukos CorporationPhase 2Completed2017-08-01Actual
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive KeratoconusNCT03442751Glaukos CorporationPhase 3Completed2019-11-01Actual
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%NCT03519386Glaukos CorporationPhase 3Completed2022-04-05Actual
Clinical Study Comparing Two Models of a Travoprost Intraocular ImplantNCT03868124Glaukos CorporationPhase 3Completed2022-06-10Actual
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular InjuriesNCT04081103Glaukos CorporationPhase 2Terminated2022-02-07Actual
Study of Exchange of Travoprost Intraocular ImplantNCT04615403Glaukos CorporationPhase 2Completed2022-02-28Actual
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye DiseaseNCT05119920Glaukos CorporationPhase 2Completed2022-07-27Actual
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of PresbyopiaNCT05124275Glaukos CorporationPhase 2Completed2022-09-06Actual
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCEDNCT05966493Glaukos CorporationPhase 2Recruiting2025-12Estimated
Travoprost Intraocular Implant in Conjunction With Cataract SurgeryNCT06061718Glaukos CorporationPhase 3Unknown2024-03-18Actual
Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionNCT06152861Glaukos CorporationPhase 2Unknown2024-08Estimated
Performance of the Travoprost Intraocular ImplantNCT06582732Glaukos CorporationPhase 2Completed2023-11-02Actual
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07075718Glaukos CorporationPhase 2Recruiting2028-03Estimated
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With KeratoconusNCT07400952Glaukos CorporationPhase 2Recruiting2027-04Estimated
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex BlepharitisNCT07400965Glaukos CorporationPhase 2Recruiting2026-09Estimated
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral ImplantNCT07495852Glaukos CorporationPhase 3Recruiting2028-06Estimated

Latest recorded trial changes